3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
41
Glioma
22
Brain Neoplasms
14
Astrocytoma
11
Neuroblastoma
10
Gliosarcoma
10
Neoplasms
8
Sarcoma, Ewing
7
Rhabdomyosarcoma
6
Sarcoma
5
Recurrence
5
Oligodendroglioma
5
Medulloblastoma
4
Small Cell Lung Carcinoma
3
Neoplasm Metastasis
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Melanoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Spinal Cord Neoplasms
1
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Interventions
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Doxorubicin
3
CTLA-4 Antigen
3
Biopsy
3
talimogene laherparepvec
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
fludarabine
1
cabozantinib
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Temozolomide
×
90 days
×
Clear all
No trials found.